9 completed, 9 unknown, 7 recruiting, 2 active not recruiting. 5 Not applicable, 2 Phase 2, 2 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Recruiting 2, Unknown 2, Completed 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Venous Thromboembolic Disease: new trials by email Literature Review of Venous Thromboembolic Disease trials Research Report on Venous Thromboembolic Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism The multifaceted interventions, Routine VTE prophylaxis - Venous Thromboembolic Disease, Pulmonary Embolism | Not applicable | Recruiting | China-Japan Friendship Hospital | 5800 | 2025-08-01 | 2025-09-17 |
| THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin Blood test - Pregnant Women, Venous Thromboembolic Disease | Recruiting | University Hospital, Clermont-Ferrand | 50 | 2024-11-22 | 2026-05-29 | |
| Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies Apixaban, Rivaroxaban, low molecular weight heparin (enoxaparin sodium) - Lymphoma, Leukemia | Not applicable | Recruiting | Medical University of Gdansk | 100 | 2024-11-22 | 2025-12-26 |
| Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism EHR (electronic health record) alert, No EHR (electronic health record) alert - Venous Thromboembolic Disease, Pulmonary Embolism and Thrombosis | Not applicable | Unknown | Scott C. Woller, MD | 152000 | 2024-06-01 | 2024-07-17 |
| Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets Full-dose anticoagulant therapy (AC), Antiplatelet therapy (AP) - Venous Thromboembolic Disease | Phase 3 | Recruiting | Centre Hospitalier Universitaire de Saint Etienne | 1400 | 2023-08-16 | 2026-05-08 |
| Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy Venous Thromboembolic Disease | Unknown | Direction Centrale du Service de Santé des Armées | 100 | 2023-06-22 | 2023-08-15 | |
| Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients Venous blood was collected from patients under fasting state to detect the level of thrombus molecular markers - Venous Thromboembolic Disease | Unknown | Qianfoshan Hospital | 300 | 2023-01-01 | 2022-08-25 | |
| Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study treatment "intervention", treatment "standard", biological assessment - Prolonged Anticoagulation, Venous Thromboembolic Disease | Phase 2 | Recruiting | Centre Hospitalier Universitaire Dijon | 72 | 2022-02-03 | 2025-12-22 |
| CHIPs-VTE Study in Hospitalized Patients With Lung Cancer Bleeding-risk based prophylaxis strategy during hospitalization and extended pharmacological treatment after discharge, Routine VTE prophylaxis in hospital - Venous Thromboembolic Disease, Pulmonary Embolism | Not applicable | Unknown | China-Japan Friendship Hospital | 3200 | 2021-12-01 | 2021-08-03 |
| Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin Venous Thromboembolic Disease | Unknown | University Hospital, Strasbourg, France | 2000 | 2021-11-18 | 2021-12-09 | |
| Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study Thrombosis, Venous, Bleeding Hemorrhage | Active not recruiting | Mount Sinai Hospital, Canada | 813 | 2021-11-01 | 2024-11-27 | |
| Clotting Parameters After Medical Abortion Thromboelastometry, Clotting Studies, Full Blood Count - Abortion Early, Abortion, Complete | Completed | NHS Lothian | 45 | 2021-03-26 | 2022-04-20 | |
| Anticoagulation Strategies for Acute Venous Thromboembolism in Patients With End-Stage Renal Disease Using USRDS Data Warfarin, Apixaban - Venous Thromboembolic Disease, Kidney Failure, Chronic | Completed | Johns Hopkins University | 14914 | 2021-01-01 | 2021-07-26 | |
| Cohort for Monitoring Patients With Venous Thromboembolic Disease Venous Thromboembolic Disease | Recruiting | University Hospital, Rouen | 2000 | 2019-11-18 | 2025-06-11 | |
| Screening for Cancer in Patients With Unprovoked VTE Fludeoxyglucose 18F - Venous Thromboembolic Disease, Respiratory Disease | Phase 4 | Unknown | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 650 | 2019-10-23 | 2021-12-09 |
| Predictors of Attempted Inferior Vena Cava Filters Retrieval. Data collection - Venous Thromboembolic Disease | Completed | Centre Hospitalier Universitaire de Saint Etienne | 356 | 2019-10-01 | 2021-04-15 | |
| Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study Venous Thromboembolic Disease | Unknown | University Hospital, Strasbourg, France | 300 | 2019-03-20 | 2019-03-25 | |
| Association Between Genetic Variant Scores and Warfarin Effect Atrial Fibrillation, Deep Vein Thrombosis | Completed | Cipherome, Inc. | 200 | 2019-02-11 | 2023-02-16 | |
| Risk Factors of Venous Thromboembolism in Women During Hormonal Exposure Case group, Control group - Venous Thromboembolic Disease | Recruiting | University Hospital, Brest | 2640 | 2017-10-24 | 2026-06-16 | |
| Long-term Outcome After Edoxaban Versus Vitamin K Antagonists for Acute VTE Observation - Venous Thromboembolic Disease, Post Thrombotic Syndrome | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1200 | 2017-04-25 | 2019-07-05 |
Showing 20 of 27. Sign in to see all of them.
Pulmonary Embolism (14) · Venous Thrombosis (11) · Venous Thromboembolism (4) · Hemorrhage (3) · Atrial Fibrillation (2) · Hematologic Neoplasms (2) · Anemia, Hemolytic, Autoimmune (1) · Atherosclerosis (1) · Atrial Flutter (1) · Cardiomyopathies (1) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Drug-Related Side Effects and Adverse Reactions (1) · Heart Diseases (1) · Hemostatic Disorders (1)
Vascular Diseases (20) · Cardiovascular Diseases (19) · Embolism and Thrombosis (18) · Embolism (14) · Respiratory Tract Diseases (14) · Lung Diseases (13) · Thrombosis (12) · Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Thromboembolism (4) · Arrhythmias, Cardiac (2) · Heart Diseases (2) · Hemorrhagic Disorders (2)
Enoxaparin (2) · Heparin, Low-Molecular-Weight (2) · Warfarin (2) · apixaban (2) · Blood Cell Count (1) · Caffeine (1) · Control Groups (1) · Crisis Intervention (1) · Data Collection (1) · Diagnosis-Related Groups (1) · Electronic Health Records (1) · Fluorodeoxyglucose F18 (1) · Hematologic Tests (1) · Hospitals (1) · Observation (1)
University Hospital, Strasbourg, France (3) · Centre Hospitalier Universitaire de Saint Etienne (2) · China-Japan Friendship Hospital (2) · ARYx Therapeutics (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · C. R. Bard (1) · Centre Hospitalier Universitaire Dijon (1) · Cipherome, Inc. (1) · Direction Centrale du Service de Santé des Armées (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · Johns Hopkins University (1) · Medical University of Gdansk (1) · Mount Sinai Hospital, Canada (1) · NHS Lothian (1) · Odense University Hospital (1)
France (10) · United States (6) · China (2) · Canada (1) · Denmark (1) · Netherlands (1) · Poland (1) · Spain (1) · United Kingdom (1)
Zhenguo Zhai, Doctor (2) · Clifford Wang, MD (1) · Daniel J Brotman, MD (1) · Dayani Nualles-Percy, MD (1) · Francis Couturaud, MD, PhD (1) · John A Kaufman, MD (1) · John J Reynolds-Wright, MBChB (1) · John Moriarty, MD (1) · Luis Jara Palomares, MD/PhD (1) · Poul Henning Madsen, MD (1) · Scott C. Woller, MD (1)
PMID 29891620, PMID 32139218, PMID 32474204, PMID 35034351, PMID 35176918, PMID 38899464, PMID 38906793, PMID 39971173
2018 (1)